RE:RE:Whoa...
kaykay22222 wrote: Look at Wishpond - similar company, stellar numbers, share buyback program, accretive M&A, but still stock market carnage. I wouldn't blame Adcore Management - actually they overdelivered in 2021.
Many of these microcaps will likely continue to trade sideways for the remainder of the year. When companies trade much below their 200 day moving average heading into Q4 then it's likely to face more selling pressure from those that purchased higher earlier in the year. This will likely present a good opportunity to purchase shares over the next few months for a likely rebound in 2022. I'm not a psychic but this is usually how it plays out.
Going forward I would like to see Adcore address the following issues:
1) less customer concentration
2) plans for the excess cash on the balance sheet
3) stabilize gross margins and bring it up to 50%
4) how much will it cost them to support Amphy going forward on an annualized basis? How much will be variable/fixed expense?
5) Have some sort of plan to attract more institutional investors. With such a small float and marketcap it will be hard to improve liquidity unless Omri decides to give some up.